Sign in
4

Changes in Ownership

FENNEC PHARMACEUTICALS INC. Filed Acc 0001468316-26-000002

Director sold 10,312 shares at $7.60 ($78,371)

  • Director acquired 15,598 shares (option exercise)
  • Director acquired 5,208 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Raykov Rosty Director 2025-12-31 Grant or award 10b5-1 +5,208 82,734 D: show line 1 in the form
Raykov Rosty Director 2026-01-02 Option exercise 10b5-1 +15,598 $2.45 $38,215 98,332 D: show line 2 in the form
Raykov Rosty Director 2026-01-02 Sale 10b5-1 −10,312 $7.60 $78,371 88,020 D: show line 3 in the form
Open-market sales · 10,312 sh · avg $7.60 · $78,371

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Raykov Rosty Director 2026-01-02 Option exercise · Stock Options 10b5-1 −15,598 $2.45 $38,215 1,618,586 D: show line 4 in the form
Loading xslF345X05/form4-01052026_040101.xml…